Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.43%7.97M | 152.03%2.98M | -19.90%2.07M | -4.18%1.81M | -37.34%1.1M | -39.60%7.41M | -60.68%1.18M | 10.53%2.58M | -32.40%1.89M | -57.47%1.76M |
| Cost of revenue | -11.17%4.48M | -13.11%1.54M | -30.42%995K | 43.46%1.32M | -23.37%633K | -9.91%5.05M | 11.98%1.77M | 1.27%1.43M | -23.50%918K | -40.83%826K |
| Gross profit | 47.08%3.48M | 346.76%1.45M | -6.85%1.07M | -49.18%494K | -49.73%468K | -64.52%2.37M | -140.97%-586K | 24.65%1.15M | -39.10%972K | -65.96%931K |
| Operating expense | 17.37%3.07M | 892.59%642K | -42.27%627K | 19.24%1.04M | -9.36%765K | 42.29%2.61M | 87.44%-81K | 33.74%1.09M | -10.05%868K | 17.71%844K |
| Selling and administrative expenses | 1.14%4.46M | 6.56%1.51M | -34.59%834K | 33.55%1.21M | -1.31%904K | -0.38%4.41M | -26.24%1.42M | 56.63%1.28M | -6.86%909K | 25.82%916K |
| -General and administrative expense | 1.14%4.46M | 6.56%1.51M | -34.59%834K | 33.55%1.21M | -1.31%904K | -0.38%4.41M | -26.24%1.42M | 56.63%1.28M | -6.86%909K | 25.82%916K |
| Total other operating income | -22.47%1.39M | -42.06%868K | 9.52%207K | 336.59%179K | 93.06%139K | -30.64%1.8M | -41.62%1.5M | 9,350.00%189K | 272.73%41K | 554.55%72K |
| Operating profit | 267.83%414K | 259.21%804K | 567.16%447K | -620.19%-541K | -441.38%-297K | -105.10%-246.68K | -124.33%-505K | -40.71%67K | -83.52%104K | -95.69%87K |
| Net non-operating interest income (expenses) | -524.75%-393.07K | -1,316.67%-170K | -846.67%-142K | -305.88%-69K | 42.11%-11K | 14.41%-62.92K | 17.30%-12K | 55.88%-15K | -54.55%-17K | -35.71%-19K |
| Non-operating interest expense | 524.75%393.07K | 1,316.67%170K | 846.67%142K | 305.88%69K | -42.11%11K | -14.41%62.92K | -17.30%12K | -55.88%15K | 54.55%17K | 35.71%19K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 106.76%20.93K | 222.63%634K | 486.54%305K | -801.15%-610K | -552.94%-308K | -106.50%-309.6K | -125.09%-517K | -34.18%52K | -85.97%87K | -96.61%68K |
| Income tax | 222.59%636.14K | 198.11%519K | 550.00%117K | 0 | 0 | -134.36%-518.92K | -164.33%-529K | -26K | -86.54%28K | -98.33%8K |
| Net income | -393.91%-615.21K | 858.33%115K | 141.03%188K | -1,133.90%-610K | -613.33%-308K | -93.56%209.32K | -99.03%12K | -1.27%78K | -85.68%59K | -96.06%60K |
| Net income continuous operations | -393.91%-615.21K | 858.33%115K | 141.03%188K | -1,133.90%-610K | -613.33%-308K | -93.56%209.32K | -99.03%12K | -1.27%78K | -85.68%59K | -96.06%60K |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | -84.87%-2.04K | -81.16%-2K | 0 | 0 | 0 |
| Net income attributable to the company | -391.07%-615.21K | 721.43%115K | 141.03%188K | -1,133.90%-610K | -613.33%-308K | -93.50%211.36K | -98.87%14K | -1.27%78K | -85.68%59K | -96.06%60K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -391.07%-615.21K | 721.43%115K | 141.03%188K | -1,133.90%-610K | -613.33%-308K | -93.50%211.36K | -98.87%14K | -1.27%78K | -85.68%59K | -96.06%60K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -385.71%-0.002 | 0.0004 | 100.00%0.0006 | -1,100.00%-0.002 | -600.00%-0.001 | -93.33%0.0007 | 0 | 0.00%0.0003 | -84.62%0.0002 | -95.92%0.0002 |
| Diluted earnings per share | -385.71%-0.002 | 0.0004 | 100.00%0.0006 | -1,100.00%-0.002 | -600.00%-0.001 | -93.33%0.0007 | 0 | 0.00%0.0003 | -84.62%0.0002 | -95.92%0.0002 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.